12 January 2021 | 09:30am
StockMarketWire.com - Tissue converter Accrol reported narrower first-half losses and said it plans to resume dividend payments this year.
The company also said it was confident full-year results would be at least in line with expectations.
Accrol said it would restore dividend payments earlier than it anticipated, forecasting a proposed final dividend increase of no less than 0.5p per ordinary share for the year ending 30 April 2021.
For the year six months ended 31 October, pre-tax losses narrowed to £0.5 million from £3 million year-on-year even as revenue fell 4.3% to £62.3 million.
The integration of Leicester Tissue Company, acquired in November 2020, for £41.8m, was progressing better than expected, the company said.